/ /

ModernMedicine Resource Center More Topics

Hepatology Resource Center

Financial, insurance issues hinder HCV treatment study saysRemoving potential barriers to treat hepatitis C virus is yet another key component to patient access, notes lead researcher.
Baby boomers face higher mortality from HCV infectionsLead researcher says economic impact of hepatitis C virus will increase unless action is taken now.
New litigation forces states to stop restricting HCV treatmentsStates had restricted Medicaid recipients’ access to drugs, but new court rulings are changing that practice.
Primary care treats chronic HCV just as well as specialistsPCPs can “play a decisive role in eradicating” hepatitis C virus in the U.S., says lead author of new study.
DAAs safer, more tolerable than interferon for HCV infectionsResearchers find that direct-acting antivirals are better tolerated in patients with hepatitis C virus infections vs. interferon-based therapy.
Elimination of hepatitis B and C now feasibleA new report finds that hepatitis B and C can be eliminated as a public health problem.
Simeprevir, sofosbuvir combo treats HCV patients with cirrhosisThe protease and polymerase inhibitor proved effective and well tolerated in patients with hepatitis C virus and cirrhosis, according to a new study.
Perinatal HCV transmission needs national conversationA new study highlights the need for hepatitis C virus screening of pregnant women to identify HCV-infected children and direct them to proper care. A significant number of babies born to women who are infected with the hepatitis C virus (HCV) remain untested for perinatal infections, according to a new study.
Some HCV patients still difficult to treatDirect-acting antiviral (DAA) agents appear to have a less robust effect in “difficult-to-treat” patients, according to new research.
Real-world factors aid HCV patient treatment decisionsA new study explores what lifestyle hepatitis C virus (HCV) patients consider when directing their course of treatement.